The Importance of the JYNNEOS Vaccine: CDC Urges Increased Vaccination Rates

The CDC's Call for Increased JYNNEOS Vaccination

The Centers for Disease Control and Prevention (CDC) are urging clinicians, health departments, and community-based organizations to continue recommending the two-dose JYNNEOS vaccine to eligible individuals. Despite the vaccine's availability at health clinics and pharmacies across the United States, the vaccination uptake has plateaued at just 25%. To protect public health and curb the spread of the virus, it is therefore essential that the uptake of the JYNNEOS vaccine is increased.

About the JYNNEOS Vaccine

JYNNEOS, developed by Bavarian Nordic A/S, is a vaccine primarily used to protect against smallpox and monkeypox, collectively referred to as mpox. The JYNNEOS vaccine has been the subject of considerable investment by the U.S. government. Bavarian Nordic A/S secured $83 million in funding from the Biomedical Advanced Research and Development Authority (BARDA) for the vaccine, marking a second investment from the U.S. government. This brings the total investment into JYNNEOS to approximately $200 million, with an additional $12 million expected to be awarded in 2021. The funding will allow for the manufacturing of liquid-frozen doses of the vaccine and will improve preparedness against smallpox and monkeypox.

Effectiveness of JYNNEOS

JYNNEOS is highly effective in preventing the spread of mpox. The vaccine has potential to protect against severe illness, hospitalization, and death. Numerous stories have been shared by individuals who have received the vaccine, providing first-hand accounts of its effectiveness and the importance of its widespread uptake. Not only does the vaccine protect the individual, but it also contributes to the overall health of the community by reducing the risk of spread.

The Current Outbreak and Measures to Reduce Risk

Currently, there is an outbreak of mpox in the Democratic Republic of Congo (DRC). The CDC provides information about ways to reduce the risk of mpox during social gatherings and sexual activity, as well as self-care tips for those recovering from the virus. However, the most effective measure to prevent the spread of the virus is through vaccination. Therefore, the increased uptake of the JYNNEOS vaccine is crucial in containing the outbreak and protecting public health.

Conclusion

The JYNNEOS vaccine plays a vital role in preventing the spread of mpox and protecting against severe illness, hospitalization, and death. The CDC's call for increased vaccination rates, coupled with substantial investment from the U.S. government, underscores the importance of this vaccine. It is therefore crucial for individuals to get vaccinated and for health professionals to continue recommending the JYNNEOS vaccine. By doing so, we can protect not only ourselves but also our communities, and contribute to the global effort to curb the spread of mpox.